Short-term Outcomes of Water Vapor Therapy (Rezūm) for BPH/LUTS in the First Czech Cohort
Urology Journal,
Vol. 18 No. 06 (2021),
18 January 2022
,
Page 699-702
https://doi.org/10.22037/uj.v18i06.6843
Abstract
Purpose: To evaluate the short-term results of water vapor therapy (Rezūm) for BPH/LUTS in the first cohort of
Czech patients.
Materials and methods: Patients with BPH and moderate to severe LUTS (N = 76) who underwent Rezūm
treatment from December 2019 to July 2020 were included in the prospective study. Prior to the procedure, they
completed the IPSS and OABv8 questionnaires and underwent uroflowmetry, transrectal ultrasound of the prostate, and PSA sampling. The parameters before and 3 months after the procedure were compared and statistically evaluated.
Results: The study protocol was completed by 92% of patients (N = 70). We observed a significant increase in
Qmax (median 17.7 vs. 8.8 mL/s, P < .001), Qave (9 vs. 4.5 mL/s, P = .001) and voided volume (241 vs. 171 mL,
P < .001) and a significant reduction in post-void residual (average 17.5 vs. 67.7 mL), prostate volume (39.3 vs.
62.3 mL) and total PSA (median 1.9 vs. 2.5 ng/mL, resp. P values < .001). There was also a significant decrease in
OABv8 score (average 7.6 vs. 16.6, P < .001) and IPSS QoL (1.6 vs. 4.0, P = .037). The improvement in the IPSS
score was apparent, yet statistically insignificant (6.8 vs. 16, P = .079).
Conclusion: Water vapor therapy is an effective and safe method of BPH/LUTS treatment in the short-term.
- benign prostatic hyperplasia
- lower urinary tract symptoms
- minimally invasive treatment
- vapor
- water
How to Cite
References
2. Dixon CM, Rijo Cedano E, Mynderse LA, Larson TR. Transurethral convective water vapor as a treatment for lower urinary tract symptomatology due to benign prostatic hyperplasia using the Rezūm(®) system: evaluation of acute ablative capabilities in the human prostate. Res Rep Urol. 2015; 7: 13–18.
3. McVary KT, Rogers T, Roehrborn CG. Rezūm Water Vapor Thermal Therapy for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: 4-Year Results From Randomized Controlled Study. Urology. 2019; 126: 171–9.
4. Boston Scientific Corporation. Minimally Invasive Prostatic Vapor Ablation - Multicenter, Single Arm Study for the Treatment of BPH in Large Prostates (Rezūm XL) [Internet]. clinicaltrials.gov; 2020 august [accessed April 18 2021]. Report No.: NCT03605745. Available from https://clinicaltrials.gov/ct2/show/NCT03605745.
5. McVary KT, Gange SN, Gittelman MC, Goldberg KA, Patel K, Shore ND, et al. Erectile and Ejaculatory Function Preserved With Convective Water Vapor Energy Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Randomized Controlled Study. J Sex Med 2016; 13: 924–33.
6. Dixon CM, Cedano ER, Pacik D, Vit V, Varga G, Wagrell L, et al. Two-year results after convective radiofrequency water vapor thermal therapy of symptomatic benign prostatic hyperplasia. Res Rep Urol. 2016; 8: 207–16.
7. Magistro G, Weinhold P, Stief CG, Graztke C. The new kids on the block: prostatic urethral lift (Urolift) and convective water vapor energy ablation (Rezum). Curr Opin Urol. 2018; 28: 294-300.
8. Das AK, Han TM, Uhr A, Roehrborn CG. Benign prostatic hyperplasia: an update on minimally invasive therapy including Aquablation. Can J Urol. 2020; 27: 2-10.
9. Woo HH, Chin PT, McNicholas TA et al. Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). BJU Int. 2011; 108: 82–8.
10. Dixon C, Cedano ER, Pacik D et al. Efficacy and Safety of Rezūm System Water Vapor Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. Urology. 2015; 86: 1042–7.
11. McVary KT, Roehrborn CG. Three-Year Outcomes of the Prospective, Randomized Controlled Rezūm System Study: Convective Radiofrequency Thermal Therapy for Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia. Urology. 2018; 111 :1–9.
12. Siena G, Cindolo L, Ferrari G et al. Water vapor therapy (Rezūm) for lower urinary tract symptoms related to benign prostatic hyperplasia: early results from the first Italian multicentric study. World J Urol. 2021; 31: 1-6.
13. McVary KT, Holland B, Beahrs JR. Water vapor thermal therapy to alleviate catheter-dependent urinary retention secondary to benign prostatic hyperplasia. Prostate Cancer Prostatic Dis. 2020; 23: 303-308.
- Abstract Viewed: 348 times
- 6843/pdf Downloaded: 307 times